DURECT
Live / Registered — Registered (as of 28 May 2024)
What this means for you
Registered since 28 May 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97401062
- Registration number
- 7402808
- Mark type
- Design + words
- Filed
- 09 May 2022
- Published for opposition
- 23 May 2023
- Registered
- 28 May 2024
- Attorney of record
- Jeremy Blackowicz
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, diseases and disorders of the endocrine system, inflammatory diseases and disorders, autoimmune diseases and disorders, cancer, neurological diseases and disorders, central nervous system diseases and disorders, acute organ injury, epigenetic diseases and disorders, and DNA methyltransferase (DNMT)-associated diseases and disorders
Owner
- Durect Corporation, Cupertino, CA, US
- Durect Corporation, Cupertino, CA, US
- Durect Corporation, Cupertino, CA, US
Prior registrations
Prosecution history
- 23 Sept 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Sept 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Sept 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Sept 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 23 Sept 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 17 Jun 2024 — DIVISIONAL PROCESSING COMPLETE
- 17 Jun 2024 — DIVISIONAL REQUEST RECEIVED
- 11 Jun 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 May 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 May 2024 — REGISTERED-PRINCIPAL REGISTER
- 23 Apr 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
- 23 Apr 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Apr 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Apr 2024 — USE AMENDMENT FILED
- 22 Apr 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL